Healingcross Pharma Private Limited vs Avesta Biotherapeutics And on 13 December, 2024
ORDER SHEET, REGARDING THE
MONETIZATION OF BIOSIMILARS, BE GIVEN DUE
CONSIDERATION IN ASSESSING THE FINANCIAL CAPABILITIES
OF THE APPLICANT AND ETC.,
CA No.430/2024 ... instructions, submits that his clients are not
agreeable to receive three biosimilars said to have
been developed by the company in discharge of the
debt